FLUARIX QUADRIVALENT2017/2018 (GlaxoSmithKline Biologicals SA)


Welcome to the PulseAid listing for the FLUARIX QUADRIVALENT drug offered from GlaxoSmithKline Biologicals SA. This pharmaceutical is classified as a VACCINE. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.

LABELER NAME / MANUFACTURER: GlaxoSmithKline Biologicals SA
NON-PROPRIETARY NAME: influenza virus vaccine
SUBSTANCE NAME: INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS
TYPE: VACCINE
PHARMA CLASS:
ROUTE: INTRAMUSCULAR
DOSAGE FORM: SUSPENSION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2017-07-07
END MARKETING DATE: 0000-00-00


FLUARIX QUADRIVALENT 2017/2018 VACCINE Details:

Item DescriptionFLUARIX QUADRIVALENT 2017/2018 from GlaxoSmithKline Biologicals SA
LABELER NAME: GlaxoSmithKline Biologicals SA
DEA SCHEDULE:
ACTIVE STRENGTH: 15; 15; 15; 15(ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL)
START MARKETING DATE: 2017-07-07
END MARKETING DATE: 0000-00-00
PRODUCT ID: 58160-907_071e5274-7118-4681-b9a6-0fd1711b427f
PRODUCT NDC: 58160-907
APPLICATION NUMBER: BLA125127

Other INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
GlaxoSmithKline Biologicals SAFLUARIX QUADRIVALENT
Seqirus Inc.FLUAD